Workflow
漳州片仔癀药业股份有限公司关于投资参与高鑫润信基金的进展公告

Group 1 - The company, through its wholly-owned subsidiary, is participating in the establishment of the Gao Xin Run Xin Fund, contributing 200 million yuan, which represents 20% of the fund [2] - The investment aims to strategically enhance the company's core competitiveness by leveraging professional investment resources and management [2] - The Gao Xin Run Xin Fund has completed the necessary registration and obtained the private investment fund registration certificate from the China Securities Investment Fund Industry Association [3] Group 2 - The fund is managed by CITIC Jin Investment Management Co., Ltd., with Bank of China as the custodian [3] - The investment is part of the company's forward-looking layout to strengthen integration capabilities along the pharmaceutical industry chain [2] - The company will closely monitor the fund's management and investment performance to mitigate risks and protect shareholder interests [3]